Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The small-GTPase RalA activates transcription of the urokinase plasminogen activator receptor (uPAR) gene via an AP1-dependent mechanism

Abstract

The urokinase plasminogen activator receptor (uPAR) focuses extracellular protease activity to the cell surface, modulates cell adhesion and activates intracellular signal transduction pathways. In a range of cancers uPAR expression often has a negative correlation with prognosis. Here we show that uPAR transcription is stimulated by V12 H-Ras, the effector loop mutant V12 H-Ras G37 and constitutively-active RalA 72L. RalA-dependent transcription required the presence of the ATF2-like AP1-site at −70 bp and the c-Jun binding motif at −184 bp in the uPAR promoter. Consistent with this, both Gal4-c-Jun- and Gal4-ATF2-fusion proteins were activated by RalA signalling through phosphorylation of their activation domains at Ser63 and Ser73 of c-Jun or Thr69 and Thr71 of ATF2. A transdominant inhibitory mutant of c-Jun N-terminal kinase (JNK) failed to inhibit uPAR transcription demonstrating that JNK activation is not a prerequisite for RalA-dependent uPAR transcription. A dominant negative inhibitor of c-Src effectively inhibited RalA-dependent uPAR transcription identifying it as a downstream effector in the RalA signalling pathway. These data provide evidence for the existence of a novel signalling pathway that links RalA to the activation of uPAR transcription via a c-Src intermediate and activation of AP1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Aguirre-Ghiso JA, Alonso DF, Farias EF, Gomez DE, de Kier Joffe' EB . 1999a Eur. J. Biochem. 263: 295–304

  • Aguirre-Ghiso JA, Frankel P, Farias EF, Lu Z, Jiang H, Olsen A, Feig LA, de Kier Joffe' EB, Foster DA . 1999b Oncogene 18: 4718–4725

  • Aguirre-Ghiso JA, Kovalski K, Ossowski L . 1999c J. Cell Biol. 147: 89–104

  • Allgayer H, Wang H, Shirasawa S, Sasazuki T, Boyd D . 1999 Br. J. Cancer 80: 1884–1891

  • Andreasen PA, Kjoller L, Christensen L, Duffy MJ . 1997 Int. J. Cancer 72: 1–22

  • Andreasen PA, Egulend R, Petersen HH . 2000 Cell Mol. Life Sci. 57: 25–40

  • Bos JL . 1989 Cancer Res. 49: 4682–4689

  • Bos JL . 1997 Biochem et Biophys Acta. 1333: M19–M31

  • Bos JL . 1998 EMBO J. 17: 6776–6782

  • de Bruyn KMT, de Rooij J, Wolthuis RMF, Rehmann H, Wesenbeek J, Cool RH, Wittinghofer AH, Bos JL . 2000 J. Biol. Chem. 275: 29761–29766

  • de Ruiter ND, Wolthuis RMF, van Dam H, Burgering BMT, Bos JL . 2000 Mol. Cell Biol. 20: 8480–8488

  • Dignam JD, Lebovitz RM, Roeder RG . 1983 Nucl. Acids Res. 11: 1475–1489

  • Dumler I, Weis A, Mayboroda OA, Maasch C, Jerke U, Haller H, Gulba DC . 1998 J. Biol. Chem. 273: 315–321

  • Frost JA, Steen H, Shapiro P, Lewis T, Ahn N, Shaw PE, Cobb MH . 1997 EMBO J. 16: 6426–6438

  • Goi T, Shipitsin M, Lu Z, Foster DA, Klinz SG, Feig LA . 2000 EMBO J. 19: 623–630

  • Hai T, Curran T . 1991 Proc. Natl. Acad. Sci. USA 88: 3720–3724

  • Hofer F, Berdeaux R, Martin GS . 1998 Curr. Biol. 8: 839–842

  • Hunter T . 1997 Cell 88: 333–346

  • Jankun J, Maher VM, McCormick JJ . 1991 Cancer Res. 51: 1221–1226

  • Janulis M, Silberman S, Ambegaokar A, Gutkind JS, Shultz RM . 1999 J. Biol. Chem. 274: 801–813

  • Johnson RS, Spiegelman BM, Hanahan D, Wisdom R . 1996 Mol. Cell Biol. 16: 4504–4511

  • Karin M, Liu Z-G, Zandi E . 1997 Curr. Opin. Cell Biol. 9: 240–245

  • Karin M . 1995 J. Biol. Chem. 270: 16483–16486

  • Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G . 1997 Nature 385: 544–548

  • Kindzelskii AL, Laska ZO, Todd RF, Petty HR . 1996 J. Immunol. 156: 297–309

  • Kindzelskii AL, Eszes MM, Todd RF, Petty HR . 1997 Biophys. J. 73: 1777–1784

  • Kops GJ, de Ruiter ND, Vries-Smits AM, Powell DR, Bos JL, Burgering BM . 1999 Nature 398: 630–634

  • Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR . 1997 J. Biol. Chem. 272: 28563–28567

  • Koshelnick Y, Ehart M, Stockinger H, Binder BR . 1999 Thromb. Haemostas. 82: 305–311

  • Lengyel E, Stepp E, Gum R, Boyd D . 1995 J. Biol. Chem. 270: 23007–23012

  • Ma Y-C, Huang J, Ali S, Lowry W, Huang X-Y . 2000 Cell 102: 635–646

  • Medema RH, Kops GJ, Bos JL, Burgering BM . 2000 Nature 404: 782–787

  • Murai H, Ikeda M, Kishida S, Ishida O, Okazaki-Kishida M, Matsuura Y, Kikuchi A . 1997 J. Biol. Chem. 272: 10483–10490

  • Muller SM, Okan E, Jones P . 2000 Biochem. Biophys. Res. Com. 270: 892–898

  • Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, Somylo AV, Weber MJ, Gonias SL . 1999 J. Cell Biol. 146: 149–164

  • Okazaki M, Kishida S, Hinoi T, Hasegawa T, Tamada M, Kataoka T, Kikuchi A . 1997 Oncogene 14: 515–521

  • Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J . 1997 Cell 89: 457–467

  • Sadowski I, Ptashne M . 1989 Nucl. Acid Res. 17: 7539

  • Sambrook J, Fritsch EF, Maniatis T . 1989 Molecular Cloning: A Laboratory Manual, 2nd edn., Cold Spring Harbour Press: Cold Spring Harbour, N.Y

  • Shetty S, Kumar A, Idell S . 1997 Mol. Cell Biol. 17: 1075–1083

  • Shields JM, Pruitt K, McFall A, Shaub A, Der CJ . 2000 Trends Cell. Biol. 10: 147–154

  • Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M . 1991 Nature 354: 494–496

  • Soravia E, Grebe A, De luca P, Helin K, Suh TT, Degan JL, Blasi F . 1995 Blood 86: 624–635

  • Tang H, Kerins DM, Hao Q, Inagami T, Vaughan DE . 1998 J. Biol. Chem. 273: 18268–18272

  • Urano T, Emkey R, Feig LA . 1996 EMBO J. 15: 810–816

  • Waltz DA, Natkin LR, Fijita RM, Wei Y, Chapman HA . 1997 J. Clin Invest. 100: 58–67

  • Webb CP, Van Aelst L, Wigler MH, Vande Woude GF . 1998 Proc. Natl. Acad. Sci. USA 95: 8773–8778

  • Westermarck J, Kähäri VM . 1999 FASEB J. 8: 781–792

  • Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenburg S, Chapman HA . 1994 J. Biol. Chem. 269: 32380–32388

  • Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA . 1996 Science 273: 1551–1555

  • Webb CP, Van Aelst L, Wigler MH, Vande Woude GF . 1998 Proc. Natl. Acad. Sci. USA 95: 8773–8778

  • White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M, Wigler MH . 1995 Cell 80: 533–541

  • Wolthuis RM, de Ruiter ND, Cool RH, Bos JL . 1997 EMBO J. 16: 6748–6761

  • Wolthius RMF, Zwartkruis F, Moen TC, Bos JL . 1998a Curr. Biol. 8: 471–474

  • Wolthuis RMF, Franke B, van Triest M, Bauer B, Cool RH, Camonis JH, Akkerman JW, Bos JL . 1998b Mol. Cell Biol. 18: 2486–2491

  • Xue W, Mizukami I, Todd III RF, Petty HR . 1997 Cancer Res. 57: 1682–1689

  • Yamamoto T, Taya S, Kaibuchi K . 1999 J. Biochem. 126: 799–803

  • Yang J-J, Kang J-S, Krauss RS . 1998 Mol. Cell Biol. 18: 2586–2595

Download references

Acknowledgements

The authors would like to thank Dr J Downward, Dr H Gille and Dr P Angel for their donations of plasmid constructs. The work was funded in part by grants from the European Social Fund to P Jones and the Wellcome Trust UK to PE Shaw.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okan, E., Drewett, V., Shaw, P. et al. The small-GTPase RalA activates transcription of the urokinase plasminogen activator receptor (uPAR) gene via an AP1-dependent mechanism. Oncogene 20, 1816–1824 (2001). https://doi.org/10.1038/sj.onc.1204260

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204260

Keywords

Search

Quick links